Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer
1 other identifier
observational
82
1 country
1
Brief Summary
This is a multicenter retrospective observational study aimed to evaluate the prevalence of osteo-metabolic complications in patients with thyroid cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2023
CompletedFirst Submitted
Initial submission to the registry
October 3, 2024
CompletedFirst Posted
Study publicly available on registry
October 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedOctober 4, 2024
October 1, 2024
1.6 years
October 3, 2024
October 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
To estimate the incidence and prevalence of osteoporosis and vertebral fractures in Patients With Thyroid Cancer
To estimate the incidence and prevalence of osteoporosis and vertebral fractures detected through DXA scan and vertebral morphometry. The effects on bone complications of the patients' clinical and biochemical characteristics will be investigated.
1 year
Interventions
Biochemical, clinical and radiological data performed for clinical practice will be retrospectively collected. Osteoporosis and vertebral fractures will be diagnosed through DXA scan and vertebral morphometry.
Eligibility Criteria
Patients with thyroid cancers who have been evaluated at the outpatient clinics of the Endocrinology Unit of the IRCCS San Raffaele Hospital and the Nuclear Medicine Unit of the Spedali Civili di Brescia.
You may qualify if:
- age ≥ 18 years
- Histological diagnosis of Thyroid Carcinoma
- radiological data from chest x-ray in lateral projection in the preoperative evaluation on which the vertebral morphometry
- Signing of the informed consent
You may not qualify if:
- Subjects not falling within the previously described criteria are excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Andrea Giustina
Milan, 20132, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Endocrinology
Study Record Dates
First Submitted
October 3, 2024
First Posted
October 4, 2024
Study Start
April 12, 2023
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
October 4, 2024
Record last verified: 2024-10